{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:29:31Z","timestamp":1784878171569,"version":"3.55.0"},"reference-count":10,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,22]]},"DOI":"10.1182\/blood.2022018586","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T16:36:40Z","timestamp":1671727000000},"page":"2655-2657","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["SARS-CoV-2 vaccination in CLL: how often is enough?"],"prefix":"10.1182","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3928-2503","authenticated-orcid":false,"given":"Sibylle C.","family":"Mellinghoff","sequence":"first","affiliation":[{"name":"1University Hospital Cologne"},{"name":"2University of Cologne"},{"name":"3German Centre for Infection Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9599-3137","authenticated-orcid":false,"given":"Oliver A.","family":"Cornely","sequence":"additional","affiliation":[{"name":"1University Hospital Cologne"},{"name":"2University of Cologne"},{"name":"3German Centre for Infection Research"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"25","key":"2022122216360544900_bib1","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood.2022017814","article-title":"Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion","volume":"140","author":"Shen","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2022122216360544900_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/10428194.2012.706285","article-title":"Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia","volume":"54","author":"Freeman","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"2022122216360544900_bib3","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1182\/blood.2020006965","article-title":"Outcomes of COVID-19 in patients with CLL: a multicenter international experience","volume":"136","author":"Mato","year":"2020","journal-title":"Blood"},{"issue":"5","key":"2022122216360544900_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41408-022-00684-8","article-title":"Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review","volume":"12","author":"Piechotta","year":"2022","journal-title":"Blood Cancer J"},{"issue":"2","key":"2022122216360544900_bib5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41375-021-01500-1","article-title":"SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia","volume":"36","author":"Mellinghoff","year":"2022","journal-title":"Leukemia"},{"key":"2022122216360544900_bib6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","article-title":"T cell responses to SARS-CoV-2 spike cross-recognize Omicron","volume":"603","author":"Keeton","year":"2022","journal-title":"Nature"},{"issue":"7","key":"2022122216360544900_bib7","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41591-021-01386-7","article-title":"CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer","volume":"27","author":"Bange","year":"2021","journal-title":"Nat Med"},{"key":"2022122216360544900_bib8","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/s41591-021-01507-2","article-title":"Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy","volume":"27","author":"Apostolidis","year":"2021","journal-title":"Nat Med"},{"issue":"10","key":"2022122216360544900_bib9","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.3324\/haematol.2022.280982","article-title":"SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia","volume":"107","author":"Mellinghoff","year":"2022","journal-title":"Haematologica"},{"issue":"10303","key":"2022122216360544900_bib10","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0140-6736(21)01694-9","article-title":"Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (ComCOV): a single-blind, randomized, non-inferiority trial","volume":"398","author":"Liu","year":"2021","journal-title":"Lancet (London, England)"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/25\/2655\/2025447\/blood_bld-2022-018586-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/25\/2655\/2025447\/blood_bld-2022-018586-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T16:36:50Z","timestamp":1671727010000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/140\/25\/2655\/493777\/SARS-CoV-2-vaccination-in-CLL-how-often-is-enough"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":10,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2022,12,22]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2022018586","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]}}}